Tizanidine, a muscle relaxant, is primarily used to handle spasticity. Customary drug screenings sometimes don’t embrace exams particularly designed to detect its presence. Consequently, a routine drug check panel is unlikely to disclose its utilization.
The absence of tizanidine from frequent drug check panels stems from a number of elements. These embrace the comparatively low potential for abuse in comparison with different managed substances, in addition to the fee and complexity related to creating and implementing particular assays. Traditionally, drug testing has centered on substances with larger charges of misuse and dependence.